case report aspiration semaglutide anesthesia 2023 American Society for Gastrointestinal Endoscopy position statement on periendoscopic management of patients on glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors Regurgitation under anesthesia in a

A supplemental new drug application (sNDA) for Rybelsus to reduce the risk of MACE in people with T2DM and established CVD and/or CKD is awaiting an FDA decision

Careful ca [...]

Specific triggers for medical consultation include achieving less than 5% body weight reduction after reaching the maintenance dose (for Wegovy, after 12 weeks at 2.4 mg as per FDA labeling), prolonged weight loss plateau despite adherence, or intolerable side effects preventing dose escalation to therapeutic levels

What happens in the first week of Semaglutide GLP-1

Studies show about 25 percent of seniors have B12 deficiency they lose the ability to absorb B12 as they can for other nutrients